Guardant Health, Inc. (NASDAQ:GH) Receives $53.29 Average Target Price from Analysts
Shares of Guardant Health, Inc. (NASDAQ:GH – Get Free Report) have been assigned an average rating of “Buy” from the twenty-one ratings firms that are currently covering the company, Marketbeat.com reports. Twenty investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average […]
Shares of Guardant Health, Inc. (NASDAQ:GH – Get Free Report) have been assigned an average rating of “Buy” from the twenty-one ratings firms that are currently covering the company, Marketbeat.com reports. Twenty investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average […]
